Home/InnoVoyce/Michael Davin

MD

Michael Davin

Advisor/Interim CEO

Therapeutic Areas

ENT Voice Disorders

InnoVoyce Pipeline

Drug	Indication	Phase
VYLO™ 455nm Laser System	ENT and Voice Health soft tissue procedures	Approved
In-Development Solutions	Voice treatments and beyond	Pre-clinical

Leadership Team at InnoVoyce

Steven Marc Zeitels, MD, FACS

Co-founder, Board Member and Scientific Consultant

Robert E. Hillman, PhD, CCC-SLP

Co-founder, Board Member and Scientific Consultant

VP of Operations

View full InnoVoyce profile